Cooper Companies | COO - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Abbott USD 1.74B 23.39B 2025-09
Align Technology USD 71.62M 133K 2026-03
AtriCure USD 49.79M 91K 2025-12
Avanos Medical USD 46.67M 216.61K 2026-03
Bausch Health Companies USD 373.46M 2.93M 2026-03
Baxter International USD 516.45M 2.17M 2026-03
Bayer EUR 982.42M 0 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.11M 14K 2026-03
Dentsply International USD 200.3M 700K 2026-03
Dexcom USD 385.9M 1.1M 2026-03
Edwards Lifesciences USD 580.7M 0 2025-12
Globus Medical USD 135.06M 449K 2025-12
Haemonetics USD 46.83M 82K 2025-12
Inogen USD 23K 0 2023-12
Insulet USD 69.26M 1.08M 2026-03
Integra LifeSciences USD 77.82M 69K 2026-03
Intuitive Surgical USD 355.17M 674K 2026-03
J&J USD 2.41B 1.74M 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.65M 231K 2026-03
Novartis USD 1.91B 10.64M 2025-12
ResMed USD 190.83M 44.86M 2026-03
STAAR Surgical USD 49.78M 377K 2026-03
Steris USD 98.07M 72K 2026-03
Stryker USD 382.98M 584K 2026-03
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.26M 70K 2026-03
Utah Medical Products USD 3.19M 3.15M 2025-12
Zimmer Biomet Holdings USD 195.5M 2.68M 2026-03